Kidney Transplant Clinical Trial 20203025

[LCID Study Number: 20203025]

The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)

The purpose of this registry study is to compare patient management and outcomes in patients who receive Prospera, an allograft rejection test, to the outcomes of a historical control group to determine Prospera’s clinical utility.

Disease/Condition: Kidney Transplant

Department: Transplantation & Hepatobiliary Diseases

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

View NCT ID 04091984 on ClinicalTrials.gov
Protocol #: 20203025
Principal Investigator(s): Edward D. Walshe
Study Coordinator(s): Ali Brien
Trial Phase: Sponsor Initiated Study Observational